AINOSTICS
Manchester
About AINOSTICS
The Sixth Sense in medical Diagnostics. At AINOSTICS we are working to identify the earliest biological signs of some of our society’s most devastating neurodegenerative conditions such as Alzheimer’s disease, Huntington's and MS, providing the best chance of success in the development of potential preventions and therapeutics by Pharma, and precise treatment planning by clinicians. We combine the most exciting medical imaging innovations with the best of artificial intelligence solutions to unlock the future of personalised diagnosis, prognosis, and therapy monitoring and planning.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.8M
- Last round: Grant (Dec 2024)
- Website: ainostics.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Health Care, Machine Learning, Medical
Social Profiles
Canonical: https://fsome.com/organization/ainostics-38874 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.